Vereinigte Staaten von Amerika

DGAP-News: CORRECTED FINANCIALS AmeraMex International Reports Financials for Its Second Quarter Ended June 30, 2022

Retrieved on: 
Monday, August 15, 2022 - 4:06pm

AmeraMex International Reports Financials for Its Second Quarter Ended June 30, 2022

Key Points: 
  • AmeraMex International Reports Financials for Its Second Quarter Ended June 30, 2022
    The issuer is solely responsible for the content of this announcement.
  • AmeraMex International, Inc. (OTCQB:AMMX), a provider of heavy equipment for logistics companies, infrastructure construction, and forestry conservation, reported financial results for its second quarter ended June 30, 2022.
  • Gross profit for the quarter was $420,000, compared to gross profit of $970,000 for the comparable quarter.
  • Net income for the quarter was $146,172 compared to net income of $78,000 for the comparable quarter.

Form 8.3 - The Vanguard Group, Inc.: Meggitt plc

Retrieved on: 
Monday, August 15, 2022 - 2:18pm

Form 8.3 - The Vanguard Group, Inc.: Meggitt plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Biffa plc

Retrieved on: 
Monday, August 15, 2022 - 2:18pm

Form 8.3 - The Vanguard Group, Inc.: Biffa plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Biffa plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.

Retrieved on: 
Monday, August 15, 2022 - 2:18pm

Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.

Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc

Retrieved on: 
Monday, August 15, 2022 - 2:18pm

Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: HomeServe plc

Retrieved on: 
Monday, August 15, 2022 - 2:18pm

Form 8.3 - The Vanguard Group, Inc.: HomeServe plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc

Retrieved on: 
Monday, August 15, 2022 - 2:18pm

Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc

Retrieved on: 
Monday, August 15, 2022 - 2:18pm

Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

DGAP-News: Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-Containing Bivalent Booster in the UK

Retrieved on: 
Monday, August 15, 2022 - 1:13pm

CAMBRIDGE, Mass.--(ACCESS WIRE)— AUGUST 15, 2022-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted conditional authorization for the use of the Omicron-containing bivalent COVID-19 booster vaccine, mRNA-1273.214 (Spikevax Bivalent Original/Omicron▼) as a booster dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older. Spikevax Bivalent Original/Omicron is a next-generation bivalent vaccine that contains mRNA-1273 (Spikevax) and a vaccine candidate targeting the Omicron variant of concern (BA.1).

Key Points: 
  • Spikevax Bivalent Original/Omicron is a next-generation bivalent vaccine that contains mRNA-1273 (Spikevax) and a vaccine candidate targeting the Omicron variant of concern (BA.1).
  • We are delighted with the MHRAs authorization of Spikevax Bivalent Original/Omicron, our next-generation COVID-19 vaccine.
  • This bivalent vaccine has an important role to play in protecting people in the UK from COVID-19 as we enter the winter months.
  • Moderna is working with The Vaccine Taskforce, UK Health Security Agency, and NHS to make
    Spikevax Bivalent Original/Omicron available to the UK public.

DGAP-News: Usio It Or Lose It: How This Company Says It Is Addressing Integrated Payment Solutions Needs

Retrieved on: 
Monday, August 15, 2022 - 1:13pm

Usio It Or Lose It: How This Company Says It Is Addressing Integrated Payment Solutions Needs

Key Points: 
  • Usio It Or Lose It: How This Company Says It Is Addressing Integrated Payment Solutions Needs
    The issuer is solely responsible for the content of this announcement.
  • Usio Inc. (NASDAQ: USIO) is one company that reports helping companies engage more seriously with the revenue stream demands of businesses that have both a physical and e-commerce presence.
  • Usio says its turnkey payment solution platform is a one-stop answer to all a companys in-going and out-going payments.
  • Usio, Inc. is a tech-enabled payment solutions provider to merchants, billers and software companies.